Who
David P. Hochman
Director and Officer
Company insider
Files Form 4 as: Director and Officer, Orchestra BioMed Holdings; Director, Motus GI Holdings; Director, Corbus Pharmaceuticals Holdings; Director and 10% owner, Naked Brand Group; Director, Orchestra Therapeutics.
In numbers
- Trades disclosed
- 182
- Buys
- 47
- Sells
- 0
- Bought
- $1.8M
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 7 Mar 2006
- Last trade
- 10 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 11 Sep 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $19K3,283 at $5.81 | filing |
| 10 Sep 2026filed 11 Sep 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $19K3,283 at $5.81 | filing |
| 10 Sep 2026filed 11 Sep 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $19K3,283 at $5.81 | filing |
| 10 Sep 2026filed 11 Sep 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $19K3,283 at $5.81 | filing |
| 3 Sep 2026filed 8 Sep 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $48K10,000 at $4.79 | filing |
| 3 Sep 2026filed 8 Sep 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $48K10,000 at $4.79 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $13K3,283 at $4.02 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $13K3,283 at $4.02 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $13K3,283 at $4.02 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $13K3,283 at $4.02 | filing |
| 1 Jun 2026filed 2 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $19K5,000 at $3.83 | filing |
| 1 Jun 2026filed 2 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $19K5,000 at $3.83 | filing |
| 15 May 2026filed 19 May 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $19K5,000 at $3.77 | filing |
| 15 May 2026filed 19 May 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $19K5,000 at $3.77 | filing |
| 25 Mar 2026filed 27 Mar 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $148K32,438 at $4.57 | filing |
| 25 Mar 2026filed 27 Mar 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $148K32,438 at $4.57 | filing |
| 13 Mar 2026filed 16 Mar 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $43K10,000 at $4.29 | filing |
| 13 Mar 2026filed 16 Mar 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $43K10,000 at $4.29 | filing |
| 12 Feb 2026filed 13 Feb 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —504,000 at $0.00 | filing |
| 12 Feb 2026filed 13 Feb 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —504,000 at $0.00 | filing |
News
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SABOBIO · manilatimes.net · 22 Oct 2026
0 headlines in the last 90 days name David P. Hochman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.